| AURA 2: Empowering discovery of post-transcriptional networks E Dassi, A Re, S Leo, T Tebaldi, L Pasini, D Peroni, A Quattrone Translation 2 (1), e27738, 2014 | 86 | 2014 |
| Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation L Amazit, L Pasini, AT Szafran, V Berno, RC Wu, M Mielke, ED Jones, ... Molecular and cellular biology, 2007 | 83 | 2007 |
| Prognostic role of circulating miRNAs in early-stage non-small cell lung cancer P Ulivi, E Petracci, G Marisi, S Baglivo, R Chiari, M Billi, M Canale, ... Journal of clinical medicine 8 (2), 131, 2019 | 55 | 2019 |
| The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy M Canale, K Andrikou, I Priano, P Cravero, L Pasini, M Urbini, A Delmonte, ... Cancers 14 (5), 1143, 2022 | 53 | 2022 |
| Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood M Notarangelo, C Zucal, A Modelska, I Pesce, G Scarduelli, C Potrich, ... EBioMedicine 43, 114-126, 2019 | 52 | 2019 |
| Liquid biopsy for the detection of resistance mechanisms in NSCLC: comparison of different blood biomarkers L Pasini, P Ulivi Journal of clinical medicine 8 (7), 998, 2019 | 44 | 2019 |
| A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy V Sidarovich, M De Mariano, S Aveic, M Pancher, V Adami, P Gatto, ... Molecular cancer therapeutics 17 (7), 1405-1415, 2018 | 35 | 2018 |
| Role of liquid biopsy in oncogene-addicted non-small cell lung cancer M Canale, L Pasini, G Bronte, A Delmonte, P Cravero, L Crinò, P Ulivi Translational Lung Cancer Research 8 (Suppl 3), S265, 2019 | 27 | 2019 |
| TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines L Pasini, A Re, T Tebaldi, G Ricci, S Boi, V Adami, M Barbareschi, ... BMC cancer 15, 1-18, 2015 | 26 | 2015 |
| Extracellular vesicles in non-small-cell lung cancer: functional role and involvement in resistance to targeted treatment and immunotherapy L Pasini, P Ulivi Cancers 12 (1), 40, 2019 | 23 | 2019 |
| Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp … A Siggillino, P Ulivi, L Pasini, MS Reda, E Chiadini, FR Tofanetti, ... Diagnostics 10 (12), 1062, 2020 | 14 | 2020 |
| Melanoma: targeting signaling pathways and RaLP L Pasini, MY Turco, L Luzi, E Aladowicz, E Fagiani, L Lanfrancone Expert Opinion on Therapeutic Targets 13 (1), 93-104, 2009 | 14 | 2009 |
| Unveiling mutational dynamics in non‐small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA L Pasini, M Notarangelo, A Vagheggini, MA Burgio, L Crino, E Chiadini, ... Molecular Oncology 15 (9), 2423-2438, 2021 | 11 | 2021 |
| Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients S Boi, T Tebaldi, A Re, C Cantaloni, V Adami, M Barbareschi, ... Genes, Chromosomes and Cancer 53 (6), 487-496, 2014 | 7 | 2014 |
| Instability of non-standard microsatellites in relation to prognosis in metastatic colorectal cancer patients F Pirini, L Pasini, G Tedaldi, E Scarpi, G Marisi, C Molinari, D Calistri, ... International Journal of Molecular Sciences 21 (10), 3532, 2020 | 6 | 2020 |
| The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer A Verlicchi, M Canale, E Chiadini, P Cravero, M Urbini, K Andrikou, ... Life 13 (9), 1915, 2023 | 3 | 2023 |
| Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences P Ulivi, A Passardi, G Marisi, E Chiadini, C Molinari, M Canale, L Pasini, ... Frontiers in pharmacology 12, 745701, 2021 | 3 | 2021 |
| Comparative analysis of free-circulating and vesicle-associated plasma microRNAs of healthy controls and early-stage lung cancer patients L Pasini, I Vannini, P Ulivi, M Tebaldi, E Petracci, F Fabbri, F Stella, ... Pharmaceutics 14 (10), 2029, 2022 | 2 | 2022 |
| Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: Safety and efficacy G Bronte, A Cafaro, L Pasini, I Priano, K Andrikou, P Cravero, MA Burgio, ... Expert Review of Anticancer Therapy 21 (8), 809-817, 2021 | 2 | 2021 |
| SHC4 (SHC (Src homology 2 domain containing) family, member 4) L Pasini, L Lanfrancone Atlas Genet Cytogenet Oncol Haematol 14 (8), 732-734, 2011 | 2 | 2011 |
Alessandro QuattroneProfessor of General Pathology, University of TrentoПодтвержден адрес электронной почты в домене unitn.it
